Receptor, Nerve Growth Factor, antagonists & inhibitors

Name
Receptor, Nerve Growth Factor, antagonists & inhibitors
Accession Number
DBCAT001753
Description

Not Available

Drugs
DrugDrug Description
RI 624Investigated for use/treatment in pain (acute or chronic).
TanezumabTanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.
Drugs & Drug Targets
DrugTargetType
RI 624Beta-nerve growth factortarget